Cytek Biosciences, Inc. CTKB Enterprise value

Enterprise value at other companies

Becton, Dickinson and CompanyBDX

$54.5B-17.3%

Thermo Fisher ScientificTMO

$225.77B+21.7%

DanaherDHR

$158.33B+0.9%

RevvityRVTY

$15.32B+11.3%

Agilent TechnologiesA

$34.39B+5.1%

Fulgent Genetics, Inc.FLGT

$481.38M+4.6%

FAQ

What is Cytek Biosciences, Inc.'s enterprise value?

Cytek Biosciences, Inc. (CTKB) reported enterprise value of $515.29M in Q2 2026.

How has Cytek Biosciences, Inc.'s enterprise value changed year-over-year?

Cytek Biosciences, Inc.'s enterprise value increased by 46.4% year-over-year, from $351.87M to $515.29M.

What is the long-term trend for Cytek Biosciences, Inc.'s enterprise value?

Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s enterprise value has grown at a -23.3% compound annual growth rate (CAGR), from $1.84B to $634.18M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.